» Articles » PMID: 25502298

Oxidative Stress and Neurobiology of Demyelination

Overview
Journal Mol Neurobiol
Date 2014 Dec 16
PMID 25502298
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Despite a large amount of research which aims at defining the pathophysiology of human demyelination (i.e., multiple sclerosis), etiological bases of disease have been unknown so far. The point of intersection of all assumed etiological factors, which are mainly based upon immunological cascades, is neuroinflammation. The precise definition of the place and role of all pathogenetic factors in the occurrence and development of the disease is of crucial importance for understanding the clinical nature and for finding more effective therapeutic options. There are few studies whose results give more precise data about the role and the importance of other factors in neuroinflammation, besides immunological ones, with regard to clinical and paraclinical correlates of the disease. The review integrates results found in previously performed studies which have evaluated oxidative stress participation in early and late neuroinflammation. The largest number of studies indicates that the use of antioxidants affects the change of neuroinflammation course under experimental conditions, which is reflected in the reduction of the severity and the total reversibility in clinical presentation of the disease, the faster achieving of remission, and the delayed and slow course of neuroinflammation. Therapies based on the knowledge of redox biology targeting free radical generation hold great promise in modulation of the neuroinflammation and its clinical presentations.

Citing Articles

Dispensable regulation of brain development and myelination by the immune-related protein Serpina3n.

Zhu M, Wang Y, Park J, Titus A, Guo F J Neurochem. 2024; 169(2):e16250.

PMID: 39450611 PMC: 11810613. DOI: 10.1111/jnc.16250.


Dispensable regulation of brain development and myelination by the immune-related protein Serpina3n.

Zhu M, Wang Y, Park J, Titus A, Guo F bioRxiv. 2024; .

PMID: 38370831 PMC: 10871299. DOI: 10.1101/2024.02.06.579239.


Nervous System Response to Neurotrauma: A Narrative Review of Cerebrovascular and Cellular Changes After Neurotrauma.

Ali H, Sula I, AbuHamdia A, Elejla S, Elrefaey A, Hamdar H J Mol Neurosci. 2024; 74(1):22.

PMID: 38367075 PMC: 10874332. DOI: 10.1007/s12031-024-02193-8.


The Emerging Role of Microglial Hv1 as a Target for Immunomodulation in Myelin Repair.

Tang Y, Wu X, Li J, Li Y, Xu X, Li G Aging Dis. 2023; 15(3):1176-1203.

PMID: 38029392 PMC: 11081154. DOI: 10.14336/AD.2023.1107.


Regulatory T cells alleviate myelin loss and cognitive dysfunction by regulating neuroinflammation and microglial pyroptosis via TLR4/MyD88/NF-κB pathway in LPC-induced demyelination.

Wang Y, Sadike D, Huang B, Li P, Wu Q, Jiang N J Neuroinflammation. 2023; 20(1):41.

PMID: 36803990 PMC: 9938996. DOI: 10.1186/s12974-023-02721-0.


References
1.
Kim S, Huri D, Snyder S . Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science. 2005; 310(5756):1966-70. DOI: 10.1126/science.1119407. View

2.
Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H . Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. J Neurosci. 2013; 33(29):12105-21. PMC: 6794065. DOI: 10.1523/JNEUROSCI.5369-12.2013. View

3.
Frischer J, Bramow S, Dal-Bianco A, Lucchinetti C, Rauschka H, Schmidbauer M . The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009; 132(Pt 5):1175-89. PMC: 2677799. DOI: 10.1093/brain/awp070. View

4.
Ladeby R, Wirenfeldt M, Garcia-Ovejero D, Fenger C, Dissing-Olesen L, Dalmau I . Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev. 2005; 48(2):196-206. DOI: 10.1016/j.brainresrev.2004.12.009. View

5.
Schreibelt G, van Horssen J, van Rossum S, Dijkstra C, Drukarch B, de Vries H . Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev. 2007; 56(2):322-30. DOI: 10.1016/j.brainresrev.2007.07.005. View